ENTA
Enanta Pharmaceuticals Inc
13.00$
+0.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 3.5% | 3.6% | 3.6% | 3.3% | 3.3% | 5.2% | 8.1% | – | 8.5% | – | 7.0% | 8.4% | – | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 93.0% | 100.0% | 98.1% | |
| 191.0% | 202.0% | 208.7% | 159.9% | 210.7% | 163.1% | 188.0% | 148.6% | 157.4% | 112.1% | 113.3% | 154.1% | 132.1% | |
| 72.9% | 91.8% | 83.5% | 74.6% | 93.7% | 75.7% | 76.3% | 54.6% | 64.1% | 48.4% | 55.8% | 65.9% | 57.8% | |
| 263.9% | 293.8% | 292.1% | 234.6% | 304.4% | 238.8% | 264.3% | 203.2% | 221.6% | 160.5% | 162.0% | 220.0% | 188.1% | |
| -163.9% | -193.8% | -192.1% | -134.6% | -204.4% | -138.8% | -164.3% | -103.2% | -121.6% | -60.5% | -69.1% | -120.0% | -90.0% | |
| 16.6% | 19.1% | 15.0% | 13.1% | 17.7% | 11.6% | 11.5% | 8.8% | 15.8% | 16.6% | 19.3% | 28.8% | 19.8% | |
| -155.9% | -189.0% | -184.8% | -128.3% | -199.8% | -133.9% | -160.5% | -99.5% | -123.4% | -64.0% | -76.3% | -135.6% | -96.7% | |
| -7.4% | -3.5% | -2.1% | -2.2% | -2.5% | -2.5% | -8.7% | 0.2% | 0.2% | 0.1% | 0.0% | 0.3% | 0.2% | |
| -148.5% | -185.6% | -182.7% | -126.1% | -197.3% | -131.4% | -151.7% | -99.7% | -123.6% | -64.1% | -76.3% | -135.8% | -96.9% | |
| -135.7% | -166.3% | -166.2% | -111.9% | -178.9% | -117.1% | -140.9% | -84.1% | -99.2% | -40.8% | -49.9% | -106.8% | -71.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.